• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2024 Fiscal Year Final Research Report

Identification of Therapeutic Targets in Oral Lichen Planus: Pathogenic T Cells and Associated Enhancer RNAs

Research Project

  • PDF
Project/Area Number 22K18401
Research Category

Grant-in-Aid for Challenging Research (Pioneering)

Allocation TypeMulti-year Fund
Review Section Medium-sized Section 57:Oral science and related fields
Research InstitutionKyushu University

Principal Investigator

Nakamura Seiji  九州大学, 歯学研究院, 特任教授 (60189040)

Co-Investigator(Kenkyū-buntansha) 前原 隆  九州大学, 歯学研究院, 助教 (10637333)
森山 雅文  九州大学, 大学病院, 助教 (20452774)
村川 泰裕  国立研究開発法人理化学研究所, 生命医科学研究センター, チームリーダー (50765469)
Project Period (FY) 2022-06-30 – 2025-03-31
Keywords口腔扁平苔癬 / T細胞 / エンハンサーRNA
Outline of Final Research Achievements

Oral lichen planus (OLP) is a chronic inflammatory mucosal disease characterized by abnormal keratinization. Despite its relatively high prevalence, its etiology remains unknown, it is resistant to treatment, and it is considered a potentially malignant disorder due to the risk of malignant transformation. Therefore, there is an urgent need to develop curative therapies through elucidation of its pathogenesis. To this end, the present study aims to isolate lymphocytes infiltrating the affected oral tissues of OLP patients and perform single-cell gene expression analysis to identify disease-specific T cells. Furthermore, by applying multiplex immunofluorescence staining to lesional tissues, we seek to identify T cell subsets involved in disease pathogenesis and to uncover upstream regulatory "switch" genes that activate the transcription factors driving these T cells.

Free Research Field

臨床免疫学

Academic Significance and Societal Importance of the Research Achievements

OLPは粘膜基底層に多数のリンパ球が浸潤する疾患であり、癌化する可能性があるために口腔潜在的悪性疾患とされている。その一方で、病態は未だ不明であり、治療法はステロイド含漱や塗布などの対症療法のみであった。そこで我々は、OLPの罹患臓器の病態解析により、治療標的となる特定の極めて特異なT細胞のサブセットを同定し、詳細な発症の分子機構を明らかにすると共に、新たな治療標的分子を明らかにすることを目的とした。

URL: 

Published: 2026-01-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi